Arca
Skip to content
Tools
Tools

Warning Letter to Aztex Enterprises Ltd.

Unspecified. See Aztex Enterprises's company page or this site's inspections.

On Oct 20, 2017, FDA's CDER sent Aztex Enterprises Ltd. a warning letter citing complaint handling, quality unit.

  • Letter date: Oct 20, 2017
  • Issued by: CDER
  • Closeout: —

The Letter

As posted on FDA.gov ↗; cited 21 CFR sections link to their page.

FDA's site did not return the letter just now. Read it on FDA.gov ↗

Recent Letters Citing Complaint handling

See them all

Record

Recipient
Mr. Grant Gillard
FDA site ID (FEI)
3003516782

Tags are assigned by Arca from the letter's text. A closeout letter means FDA found the firm's corrections adequate; no closeout does not mean the issues are unresolved. FDA warning letters

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.